Herbst, R S, Arkenau, H T, Santana-Davila, R, Calvo, E, Paz-Ares, L, Cassier, P A, Bendell, J, Penel, N, Krebs, M G, Martin-Liberal, J, Isambert, N, Soriano, A, Wermke, M, Cultrera, J, Gao, L, Widau, R C, Mi, G, Jin, J, Ferry, D, Fuchs, C S, Petrylak, D P & Chau, I 2019, ' Ramucirumab plus pembrolizumab in patients with previously treated advanced non-small-cell lung cancer, gastro-oesophageal cancer, or urothelial carcinomas (JVDF) : a multicohort, non-randomised, open-label, phase 1a/b trial ', The Lancet Oncology, vol. 20, no. 8, pp. 1109-1123 . https://doi.org/10.1016/S1470-2045(19)30458-9